Kidney Res Clin Pract.  2018 Jun;37(2):112-118. 10.23876/j.krcp.2018.37.2.112.

Hemodialysis as a life-sustaining treatment at the end of life

Affiliations
  • 1Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea. wizdocrc@gmail.com
  • 2Department of Thoracic Surgery, Dongguk University Ilsan Hospital, Goyang, Korea.

Abstract

The Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life came into effect on February 4th, 2018, in South Korea. Based on the Act, all Koreans over the age of 19 years can decide whether to refuse life-sustaining treatments at the end of life via advance directive or physician orders. Hemodialysis is one of the options designated in the Act as a life-sustaining treatment that can be withheld or withdrawn near death. However, hemodialysis has unique features. So, it is not easy to determine the best candidates for withholding/withdrawing hemodialysis at the end of life. Thus, it is necessary to investigate the meaning and implications of hemodialysis at the end of life with ethical consideration of futility and withholding or withdrawal of intervention.

Keyword

Hemodialysis; Life-sustaining treatment; Terminal care

MeSH Terms

Advance Directives
Hospices
Humans
Korea
Medical Futility
Palliative Care
Renal Dialysis*
Terminal Care
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr